Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting

Full text
Author(s):
Mendes, Fernanda Rodrigues [1, 2] ; da Silva, Wellington Fernandes [1, 2] ; da Costa Bandeira de Melo, Raphael [1, 3, 4] ; Silveira, Douglas Rafaele Almeida [2] ; Velloso, Elvira Deolinda Rodrigues Pereira [1, 3] ; Rocha, Vanderson [1, 2, 3] ; Rego, Eduardo Magalhaes [1, 2, 3]
Total Authors: 7
Affiliation:
[1] Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo ICESP, Div Hematol, Av Dr Arnaldo 251, BR-01246000 Sao Paulo, SP - Brazil
[2] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Dept Hematol, Lab Med Invest Pathogenesis & Target, Sao Paulo - Brazil
[3] Univ Sao Paulo, Hosp Clin, Fac Med HCFMUSP, Sao Paulo - Brazil
[4] Kings Coll London, Sch Canc & Pharmaceut Sci, Myeloid Leukaemia Genom & Biol Grp, London SE5 8AF - England
Total Affiliations: 4
Document type: Journal article
Source: ANNALS OF HEMATOLOGY; v. 101, n. 1 OCT 2021.
Web of Science Citations: 0
Abstract

Despite advances in supportive measures, acute myeloid leukemia (AML) remission induction still has a high mortality rate in real-world studies as compared to prospective reports. We analyzed data from 206 AML adult patients treated with conventional chemotherapy. The primary endpoint was the 60-day mortality rate, aiming to find risk factors and to examine the role of anti-infection prophylaxis. The 60-day mortality rate was 26%, raising to 41% among those older than 60 years. Complete response was documented at the end of induction in 49%. The final survival model showed that age > 60 years (HR 3.2), Gram-negative colonization (HR 3), monocytic AML (HR 1.8), C-reactive protein (CRP) > 15 mg/dL (HR 10), and an adverse risk in the genetic stratification (HR 3) were associated with induction death. Multidrug-resistant bacteria colonization, thrombosis, and AKI were documented in 71%, 12%, and 66% of the cohort, respectively. Antibacterial and antifungal prophylaxis did not improve outcomes in this study. Our report corroborated the higher mortality during AML induction compared to real-world data from the USA and Europe. In line with other publications, age and cytogenetic stratification influenced early death in this cohort. Noticeably, Gram-negative colonization, monocytic AML, and CRP were also significant to early mortality. (AU)

FAPESP's process: 13/08135-2 - CTC - Center for Cell-Based Therapy
Grantee:Dimas Tadeu Covas
Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC